Providing Today's Patients with Medicines of the Future.
Staff
2017-2019 Net Profit CAGR
Current Brands of Products
Innovative Product Candidates
Covering Class III Hospitals
Covering Other Hospitals & Medical Institutions
Nov 10, 2025, Nanjing China， Simcere Pharmaceutical Group (2096.HK) announced that its regulatory T cells（Treg）-preferential IL-2 mutant Fc fusion pro...
November 7, 2025 - Simcere Zaiming, an oncology-focused biopharmaceutical company and a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096), a...
The 45th International Society of Urology Annual Meeting (SIU2025) was held in Edinburgh, UK, from October 29 to November 1, 2025. The phase I clinica...
Shanghai China / BELTSVILLE, Md. USA, October 16 2025 – Simcere Zaiming, an oncology-focused biopharmaceutical company and a subsidiary of Simcere Pha...